Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | LDC1267 |
Synonyms | |
Therapy Description |
LDC1267 is a specific TAM kinase inhibitor, with activity against TYRO3, AXL, and MERTK, which potentially enhances anti-tumor immune response and decreases tumor metastasis (PMID: 24553136, PMID: 32714402). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LDC1267 | LDC 1267|LDC-1267 | AXL Inhibitor 30 MERTK Inhibitor 13 TYRO3 Inhibitor 8 | LDC1267 is a specific TAM kinase inhibitor, with activity against TYRO3, AXL, and MERTK, which potentially enhances anti-tumor immune response and decreases tumor metastasis (PMID: 24553136, PMID: 32714402). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|